Climacteric medicine: European Menopause and Andropause Society (EMAS) statements on postmenopausal hormonal therapy

Maturitas
Sven O SkoubyEuropean Menopause and Andropause Society (EMAS)

Abstract

Hormonal therapy (HT) is one of the most frequently prescribed drug regimens for women after the age of 50 years. HT has been developed progressively since the 1960s to provide estrogen to those women (a) who require relief of symptoms which have resulted from reduced circulating estrogen or (b) to act as an anti-resorptive agent to counteract the effect of the increased bone turnover which occurs with falling menopausal estrogen levels and which results in loss of bone mass leading to postmenopausal osteoporosis. However, a large number of women pass through the menopausal transition without experiencing distress as a result of the natural fall in estrogen hormone levels and since the introduction HT has been thought to be associated with a number of health benefits that have been tested in clinical trials but not substantiated. In women experiencing distressing climacteric symptoms double-blind randomised controlled clinical trials with a variety of HT regimens have shown that HT of any type provides symptom relief with no alternative treatment of similar effect. The dose and regimen of HT need to be individualised and in general the appropriate dose is dependent on the menopausal age. Women experiencing urogenital estrogen d...Continue Reading

Citations

Feb 24, 2005·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Steven BoonenJean-Yves Reginster
Sep 8, 2005·Menopause : the Journal of the North American Menopause Society·Maurizio RinaldiAlberto Bacchi-Modena
Jul 1, 2007·Women's Health·Alessandra Graziottin
Jul 26, 2006·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Andrea R GenazzaniEsme A Nijland
Jan 20, 2010·Climacteric : the Journal of the International Menopause Society·K HanckeD Denschlag
Jun 24, 2008·Climacteric : the Journal of the International Menopause Society·N KalleinenP Polo-Kantola
Mar 18, 2008·Gastroentérologie Clinique Et Biologique·C Delluc, R Benamouzig
Sep 16, 2010·Annals of the New York Academy of Sciences·Alessandra Graziottin
Jun 10, 2006·Gynécologie, obstétrique & fertilité·C JaminM-C Micheletti
May 11, 2005·Maturitas·Alessandra Graziottin
Jun 20, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N BrusselaersJ Lagergren
Mar 20, 2019·Menopause : the Journal of the North American Menopause Society·Theresa BurkardChristoph R Meier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Epidemiology of Aging

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.